Evidence map›Paper›PMID 36990199›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023

Discovery of a novel sub-lineage of multi-drug resistant Shigella flexneri in Southern California.

Edwin Kamau, Paul C Adamson, John Crandall, Rituparna Mukhopadhyay, Shangxin Yang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Characterization of azithromycin-resistantMicrobiology spectrum · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Edwin KamauDepartment of Pathology and Laboratory Medicine, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California.
Paul C AdamsonDivision of Infectious Diseases, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California.
John CrandallMicrobial Diseases Laboratory, California Department of Public Health, Richmond, California.
Rituparna MukhopadhyayMicrobial Diseases Laboratory, California Department of Public Health, Richmond, California.
Shangxin YangDepartment of Pathology and Laboratory Medicine, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California. Electronic address: shangxinyang@mednet.ucla.edu.

Funding

Antimicrobial resistance in Neisseria gonorrhoeae among men on PrEP in VietnamK01TW012170 · FIC · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ADAMSON, PAUL C · 2021 to 2025
$958k
FIC NIH HHS K01 TW012170
6 · The paper itself

Abstract

Clustered outbreaks of multi-drug resistant (MDR) Shigella are on the rise among men who have sex with men (MSM). Identification of MDR sub-lineages is critical for clinical management and public health interventions. Here, we describe a novel MDR sub-lineage of Shigella flexneri isolated from an MSM patient without a travel history in Southern California. Detailed genomic characterization of this novel strain would serve as a reference to aid monitoring and future outbreak investigation of MDR Shigella among MSM.

Indexed as

Dysentery, BacillarySexual and Gender MinoritiesShigellaAnti-Bacterial AgentsCaliforniaHomosexuality, MaleHumansMaleShigella flexneriAnti-Bacterial AgentsMen who have sex with menMulti-drug resistant ShigellaShigella flexneriWhole genome sequencing

Identifiers

PMID36990199
PMCPMC10275642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.